CardioInsight Technologies Inc., a Cleveland, Ohio-based developer of non-invasive electrocardiographic mapping technology, closed a $6m Series B round of funding.
Draper Triangle Ventures, Case Technology Ventures, Dr. Michel Haissaguerre, a leading international electrophysiologist, and Company Management participated in the round.
This funding will enable the company to accelerate commercialization of its technology, which allows doctors to accurately diagnose and treat cardiac arrhythmias and congestive heart failure.
CardioInsight’s electrocardiographic mapping technology gathers electrical information about the heart from an electrode device placed on a patient’s body and combines it with images from a CT scan to provide 3D maps of the electrical activity of the heart.
The technology’s strengths have been demonstrated in more than 125 pre-procedural and intra-procedural patient studies at clinical centers including University Hospitals of Cleveland, Loyola Chicago, and Hôpital Cardiologique du Haut–Lévèque in Bordeaux, France.
With the close of the investment round, CardioInsight will accelerate and expand its clinical studies program to include new centers such as the Cleveland Clinic and the Penn Medicine Hospital University of Pennsylvania, as well as to complete the product development program for the first commercial system, targeted for regulatory approval and commercial release in 2011.